SGK3 promotes estrogen receptor‐positive breast cancer proliferation by activating STAT3/ZMIZ2 pathway to stabilise β‐catenin

Lie Yuan(Chongqing Medical and Pharmaceutical College), Weiying Zhou(Chongqing Medical University), Xu Liu(Chongqing Medical and Pharmaceutical College), Gang Wang(Wuhan University), Xiaoli Li(Fujian Medical University), Bo Chen(Unknown), Na Qu(Yangzhou University), Yongqing Cai(Army Medical University), Yuanli Wu(Chongqing Medical University), Duanfang Zhou(Chongqing Medical University)
British Journal of Pharmacology
January 28, 2025
Cited by 1


Related Papers